Exabis Library
Welcome to the e-CCO Library!
P217: Prevalence of COVID-19 in IBD patients treated with infliximab and vedolizumab in Croatian tertiary center – clinical observation of a case series
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P217: Risk factors of primary sclerosing cholangitis and cirrhosis in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P217: Serological biomarkers of type VI collagen remodelling reflect endoscopically and clinically active Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P217: The relationship between thiopurine use during pregnancy and anemia in the offspring during the first year of life
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P217: Usefulness of systematic liver biopsy during a surgery for inflammatory bowel disease for the diagnosis of primary sclerosing cholangitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P217: Volatile organic metabolites to predict clinical response to biological therapy in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P218 Linked colour imaging predicts the risk of the clinical relapse in ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P218: Accuracy of Ultrasonography in Assessing Disease Activity in Pediatric Ulcerative Colitis: Preliminary Results of a two-center study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P218: Assessment of the degree of intestinal destruction in Crohn's disease at the time of diagnosis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P218: It is time to grow up: readiness is associated with better outcomes in a prospective study of pediatric transition patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P218: Oral manifestations in inflammatory bowel disease patients under anti-tumour necrosis factor treatment
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P218: Over 30% of active flares in inflammatory bowel disease patients are associated with gastrointestinal infectious agents
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P218: The cost-effectiveness of biological therapy cycles in the management of Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P218: Venous thromboembolism in a Finnish IBD cohort
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P219 Disease-specific avoidance is a predictor for fatigue in inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P219: Accuracy of imaging for the preoperative measurement of the ileocolonic Crohn’s disease length: results of a prospective cohort study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P219: An application of artificial intelligence in Inflammatory Bowel Disease detection
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P219: Impact of COVID-19 pandemic in patients with a first consultation for suspected inflammatory bowel disease.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P219: Inflammatory bowel disease in children is a challenging diagnosis when overlaps with coeliac disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P219: Migraine Is Associated with the Development of Inflammatory Bowel Disease: A Nationwide, Population-Based Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM